Regeneron Can't Escape Feds' Medicare Kickback Case
Regeneron
Pharmaceuticals Inc. must face claims that the millions of dollars it funneled
to a patient-support charity were kickbacks meant to convince doctors to
prescribe its pricey eye disease drug, a Massachusetts federal judge ruled
Friday.
Order
attached |
No comments:
Post a Comment